FrancophonIA/ELRC3.0 huggingface dataset:
English: Table 2: Results of study 37,609 (randomized, group comparative clinical study comparing safety and efficacy of Puregon with urinary FSH in ovulation induction).
Croatian: Tablica 2: Rezultati Ispitivanja 37 609 (randomizirano, grupno komparativno kliničko ispitivanje usporedbe sigurnosti i djelotvornosti lijeka Puregon i urinarnog FSH-a u poticanju ovulacije).
English: Puregon is usually prescribed at a dose of 450 IU per week, mostly in 3 dosages of 150 IU, in combination with another hormone (hCG), for at least 3 to 4 months.
Croatian: Puregon se obično daje u dozi od 450 IU tjedno, većinom u tri odijeljene doze od 150 IU, u kombinaciji s drugim hormonom (hCG).
English: Puregon is used in the treatment of women undergoing ovarian induction or controlled ovarian hyperstimulation in assisted reproduction programmes.
Croatian: Puregon se koristi u liječenju žena koje su podvrgnute poticanju ili kontroliranoj hiperstimulaciji jajnika u sklopu postupaka medicinski potpomognute oplodnje.
English: If you are breast-feeding, tell your doctor before using Puregon.
Croatian: Ako dojite, obavijestite o tome svog liječnika prije uzimanja lijeka Puregon.
English: After subcutaneous administration of Puregon, maximum concentration of FSH is reached within about 12 hours.
Croatian: Nakon supkutane primjene lijeka Puregon maksimalna koncentracija FSH-a postiže se unutar otprilike 12 sati.
English: If you: • are allergic to follitropin beta or any of the other ingredients of Puregon (listed in section 6)
Croatian: U slučajevima: • ako ste alergični na folitropin beta ili neki drugi sastojak ovog lijeka (naveden u dijelu 6.)
English: If you inject yourself with Puregon, follow the instructions for use in the next section, to give Puregon properly and with minimal discomfort.
Croatian: Ako sami injicirate Puregon, slijedite upute za primjenu u daljnjem tekstu kako biste Puregon primijenili pravilno i uz minimalnu neugodu.
English: Puregon should be given at a dosage of 450 IU/week, preferably divided in 3 dosages of 150 IU, concomitantly with hCG.
Croatian: Puregon se mora davati u dozi od 450 IU/tjedan, preporučljivo u 3 odijeljene doze od 150 IU, istodobno uz hCG.
English: After intramuscular or subcutaneous administration of Puregon, maximum concentrations of FSH are reached within about 12 hours.
Croatian: Nakon intramuskularne ili supkutane primjene lijeka Puregon maksimalne koncentracije FSH-a postižu se unutar otprilike 12 sati.
English: Solution for injection 1 vial containing 0.5 mL 5 vials each containing 0.5 mL 10 vials each containing 0.5 mL
Croatian: Otopina za injekciju 1 bočica koja sadrži 0,5 ml 5 bočica; svaka sadrži 0,5 ml 10 bočica; svaka sadrži 0,5 ml
English: For use only with the Puregon Pen.
Croatian: Samo za primjenu s brizgalicom Puregon Pen.
English: Thromboembolic events, both in association with and separate from OHSS, have been reported following treatment with gonadotropins, including Puregon.
Croatian: Tromboembolijski događaji, kako oni povezani tako i oni nepovezani s OHSS-om, prijavljeni su nakon liječenja gonadotropinima, uključujući Puregon.
English: Furthermore Puregon can be used to promote multiple follicular development in medically assisted reproduction programs [e.g. in vitro fertilisation/embryo transfer (IVF/ET), gamete intrafallopian transfer (GIFT) and intracytoplasmic sperm injection (ICSI)].
Croatian: Nadalje, Puregon se može koristiti za poticanje razvoja većeg broja folikula u postupcima medicinski potpomognute oplodnje [npr. in vitro oplodnja/prijenos embrija (IVF/ET), prijenos gamete u jajovod (GIFT) ili intracitoplazmatsko injiciranje spermija (ICSI)].
English: A. MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE
Croatian: PROIZVOĐAČ(I) BIOLOŠKE(IH) DJELATNE(IH) TVARI I PROIZVOĐAČ(I) ODGOVORAN (ODGOVORNI) ZA PUŠTANJE SERIJE LIJEKA U PROMET
English: A gentle massage of the site - while still maintaining pressure - helps disperse the Puregon solution and relieve any discomfort.
Croatian: Nježna masaža mjesta uboda, uz zadržavanje pritiska, poboljšava raspodjelu Puregon otopine i ublažava neugodu.
English: In males Puregon is used in the treatment of deficient spermatogenesis due to hypogonadotrophic hypogonadism.
Croatian: U muškaraca se Puregon koristi u liječenju nedostatne spermatogeneze uslijed hipogonadotropnog hipogonadizma.
English: In women undergoing Assisted Reproduction Technologies (ART) procedures, the risk of a multiple pregnancy is mainly related to the number of embryos transferred.
Croatian: U žena koje prolaze postupke medicinski potpomognute oplodnje , rizik od višeplodne trudnoće većinom je povezan s brojem prenijetih embrija.
English: It is unlikely that Puregon is passed into breast milk.
Croatian: Nije vjerojatno da će Puregon prijeći u majčino mlijeko.
English: Mean no. of oocytes retrieved Mean total dose (no. of 75 IU ampoules) Mean duration of FSH stimulation (days)
Croatian: Prosječan broj dobivenih oocita Prosječna ukupna doza (broj ampula od 75 IU) Prosječno trajanje FSH stimulacije (dani)
English: • are allergic to follitropin beta or any of the other ingredients of Puregon (listed in section 6)
Croatian: • ako ste alergični na folitropin beta ili neki drugi sastojak ovog lijeka (naveden u dijelu 6.)
English: This may be of particular relevance when switching between the pen-injector and a conventional syringe within one treatment cycle.
Croatian: To može biti naročito važno ako se u istom ciklusu naizmjence koriste brizgalica i obična štrcaljka.
English: Concomitant use of Puregon and clomifene citrate may enhance the follicular response.
Croatian: Istodobna primjena lijeka Puregon i klomifen citrata može pojačati folikularni odgovor.
English: For males and females
Croatian: Za muškarce i žene
English: Using the pen, injection of Puregon can be carried out by the patient, provided that proper instructions are given by the physician.
Croatian: Koristeći brizgalicu, injekciju lijeka Puregon može primijeniti sam bolesnik/bolesnica ako mu/joj je liječnik dao odgovarajuće upute.
English: Puregon can be given either alone, or, to prevent premature luteinisation, in combination with a GnRH agonist or antagonist.
Croatian: Puregon se može primjenjivati kao jedini lijek ili u kombinaciji s agonistom ili antagonistom GnRH-a radi sprječavanja prerane luteinizacije.
English: Puregon solution for injection comes in a glass vial.
Croatian: Puregon otopina za injekciju nalazi se u staklenoj bočici.
English: If a GnRH agonist (a medicine used to prevent early ovulation) has been given, higher doses of Puregon may be needed.
Croatian: Ako se primjenjuje agonist GnRH-a (lijek koji sprječava preranu ovulaciju), možda će biti potrebne veće doze lijeka Puregon.
English: The use of Puregon during pregnancy is not indicated.
Croatian: Puregon nije indiciran za primjenu u trudnoći.
English:  12 mm  15 mm  18 mm
Croatian: Prosječan broj folikula 12 mm 15 mm
English: For patient convenience, Puregon may be stored at or below 25ºC by the patient for a single period of not more than 3 months.
Croatian: Radi lakše uporabe, bolesnik može jednokratno čuvati Puregon na temperaturi od ili ispod 25°C najdulje 3 mjeseca.
English: Medical conditions that contraindicate pregnancy should also be evaluated before starting treatment with Puregon.
Croatian: Prije početka liječenja lijekom Puregon potrebno je procijeniti i zdravstvena stanja koja su kontraindikacija za trudnoću.
English: Such patients are unresponsive to Puregon/hCG therapy.
Croatian: Takvi bolesnici neće odgovoriti na liječenje lijekom Puregon i hCG-om.
English: • Each cartridge contains the active substance follitropin beta, a hormone known as follicle-stimulating hormone (FSH) in a strength of 833 IU/mL aqueous solution.
Croatian: • Jedan uložak sadrži djelatnu tvar folitropin beta, hormon poznat kao folikulostimulirajući hormon (FSH), u koncentraciji od 833 IU/ml vodene otopine.
English: Puregon cartridges are not designed to allow any other drug to be mixed in the cartridges.
Croatian: Puregon ulošci izrađeni su tako da se u uložak ne može umiješati drugi lijek.
English: The table below lists the adverse reactions with follitropin beta reported in a clinical trial in males (30 patients dosed), according to system organ class and frequency; common (≥ 1/100 to < 1/10).
Croatian: U sljedećoj su tablici nuspojave folitropina beta prijavljene u kliničkom ispitivanju u muškaraca (30 je bolesnika primilo dozu) navedene prema organskim sustavima i učestalosti; često (≥1/100 i <1/10).
English: How to use Puregon
Croatian: Kako primjenjivati Puregon
English: For ovulation induction, Puregon resulted in a lower median total dose and shorter median duration of treatment when compared to urinary FSH.
Croatian: Kad se primjenjivao za poticanje ovulacije, medijan ukupne doze lijeka Puregon je bio manji, a medijan trajanja liječenja kraći nego kod primjene urinarnog FSH-a.
English: How to store Puregon
Croatian: Kako čuvati Puregon
English: 1025 IU recombinant FSH activity/1.230 mL Net content 900 IU
Croatian: 1025 IU aktivnosti rekombinantnog FSH/1,230 ml Neto sadržaj 900 IU
English: Puregon treatment is then stopped and ovulation will be induced by giving human chorionic gonadotrophin (hCG).
Croatian: Tada se liječenje lijekom Puregon prekida i potiče se ovulacija davanjem humanog korionskog gonadotropina (hCG).
English: Subcutaneous (SC) use.
Croatian: Potkožna primjena (s.c.)
English: This is produced by recombinant DNA technology, using a Chinese hamster ovary cell line transfected with the human FSH subunit genes.
Croatian: Puregon sadrži rekombinantni FSH, koji se proizvodi tehnologijom rekombinantne DNK pomoću stanične linije jajnika kineskog hrčka, koja se transfecira podvrstom gena humanog FSH-a.
English: This dose may be adjusted during your treatment period.
Croatian: Vaš liječnik će odrediti početnu dozu koja se može prilagođavati tijekom liječenja.
English: For controlled ovarian stimulation, Puregon resulted in a higher number of oocytes retrieved at a lower total dose and with a shorter treatment period, when compared to urinary FSH.
Croatian: Kad se primjenjivao za kontroliranu stimulaciju jajnika, ishod liječenja lijekom Puregon bio je veći broj dobivenih oocita pri nižoj ukupnoj dozi i kraćem trajanju liječenja u usporedbi s urinarnim FSH.
English: 0.5 mL of solution in 3 mL vial (type I glass) with stopper (chlorobutyl rubber).
Croatian: 0,5 ml otopine u bočici volumena 3 ml (staklo tipa I ) s čepom (klorobutilna guma).
English: Puregon showed no mutagenic potential in the Ames test and in the in vitro chromosome aberration test with human lymphocytes.
Croatian: Amesov test i in vitro test kromosomskih aberacija s ljudskim limfocitima nisu pokazali mutageni potencijal lijeka Puregon.
English: Men
Croatian: I
English: After pituitary desensitisation induced by a GnRH agonist, a higher dose of Puregon may be necessary to achieve an adequate follicular response.
Croatian: Nakon desenzibilizacije hipofize agonistom GnRH-a, za postizanje odgovarajućeg folikularnog odgovora može biti potrebna veća doza lijeka Puregon.
English: The administration of Puregon is then discontinued and ovulation can be induced by administering human chorionic gonadotrophin (hCG).
Croatian: Nakon toga se primjena lijeka Puregon prekida, a ovulacija se može potaknuti primjenom humanog korionskog gonadotropina (engl. human chorionic gonadotrophin, hCG).
English: In rare instances, thromboembolism has been associated with follitropin beta /hCG therapy as with other gonadotrophins.
Croatian: Kao i liječenje drugim gonadotropinima, liječenje folitropinom beta i hCG-om se u rijetkim slučajevima povezuje s tromboembolijom.
English: CARTRIDGE TEXT Puregon 300 IU/0.36 mL
Croatian: TEKST NA ULOŠKU Puregon 300 IU/0,36 ml
English: Ovarian and Other Reproductive System Tumours There have been reports of ovarian and other reproductive system tumors in women who have had infertility treatment.
Croatian: Zabilježeni su tumori jajnika i drugih reproduktivnih organa u žena koje su se liječile zbog neplodnosti.
English: Puregon solution for injection is designed for use in conjunction with the Puregon Pen.
Croatian: Puregon otopina za injekciju namijenjena je za uporabu s brizgalicom Puregon Pen.
English: CARTRIDGE TEXT Puregon 900 IU/1.08 mL
Croatian: TEKST NA ULOŠKU Puregon 900 IU/1,08 ml
English: The contents of the vial should be used immediately after piercing of the rubber stopper.
Croatian: Sadržaj bočice mora se upotrijebiti odmah nakon što se probije gumeni čep.
English: You should use sterile disposable syringes and needles for the administration of Puregon.
Croatian: Za primjenu lijeka Puregon morate koristiti sterilne štrcaljke i igle za jednokratnu uporabu.
English: When using a GnRH agonist, a higher total treatment dose of Puregon may be required to achieve an adequate follicular response.
Croatian: Kad se primjenjuje agonist GnRH-a, za postizanje adekvatnog odgovora folikula možda će biti potrebna veća ukupna doza lijeka Puregon.
English: Multiple pregnancies and births have been reported for all gonadotropin treatments, including Puregon.
Croatian: Kod svih liječenja gonadotropinima, uključujući i Puregon, zabilježene su višeplodne trudnoće i porođaji.
English: Puregon solution for injection in cartridges has been developed for use in the Puregon Pen and should be administered subcutaneously.
Croatian: Puregon otopina za injekciju u ulošcima namijenjena je za primjenu u injekcijskoj brizgalici Puregon Pen i primjenjuje se supkutano.
English: CARTRIDGE TEXT Puregon 600 IU/0.72 mL
Croatian: TEKST NA ULOŠKU Puregon 600 IU/0,72 ml
English: VIAL TEXT Puregon 225 IU/0.5 mL
Croatian: TEKST NA BOČICI Puregon 225 IU/0,5 ml
English: Puregon 900 IU/1.08 mL solution for injection
Croatian: Puregon 900 IU/1,08 ml otopina za injekciju
English: Too high a dose of Puregon may cause hyperstimulation of the ovaries (OHSS).
Croatian: Prevelika doza lijeka Puregon može uzrokovati hiperstimulaciju jajnika (OHSS), što možete osjetiti kao bol u trbuhu.
English: VIAL TEXT Puregon 75 IU/0.5 mL
Croatian: TEKST NA BOČICI Puregon 75 IU/0,5 ml
English: Puregon 150 IU/0.18 mL solution for injection Puregon 300 IU/0.36 mL solution for injection Puregon 600 IU/0.72 mL solution for injection Puregon 900 IU/1.08 mL solution for injection
Croatian: Puregon 150 IU/0,18 ml otopina za injekciju Puregon 300 IU/0,36 ml otopina za injekciju Puregon 600 IU/0,72 ml otopina za injekciju Puregon 900 IU/1,08 ml otopina za injekciju
English: Puregon 300 IU/0.36 mL solution for injection
Croatian: Puregon 300 IU/0,36 ml otopina za injekciju
English: In men who are infertile due to lowered hormone levels, Puregon can be used for the production of sperm.
Croatian: Puregon se može koristiti za stvaranje spermija u muškaraca koji su neplodni zbog smanjene razine hormona.
English: Puregon 600 IU/0.72 mL solution for injection
Croatian: Puregon 600 IU/0,72 ml otopina za injekciju
English: Puregon 150 IU/0.18 mL solution for injection Puregon 300 IU/0.36 mL solution for injection Puregon 600 IU/0.72 mL solution for injection Puregon 900 IU/1.08 mL solution for injection follitropin beta
Croatian: Puregon 150 IU/0,18 ml otopina za injekciju Puregon 300 IU/0,36 ml otopina za injekciju Puregon 600 IU/0,72 ml otopina za injekciju Puregon 900 IU/1,08 ml otopina za injekciju folitropin beta
English: Puregon 50 IU/0.5 mL solution for injection Puregon 75 IU/0.5 mL solution for injection Puregon 100 IU/0.5 mL solution for injection Puregon 150 IU/0.5 mL solution for injection Puregon 200 IU/0.5 mL solution for injection Puregon 225 IU/0.5 mL solution for injection follitropin beta
Croatian: Puregon 50 IU/0,5 ml otopina za injekciju Puregon 75 IU/0,5 ml otopina za injekciju Puregon 100 IU/0,5 ml otopina za injekciju Puregon 150 IU/0,5 ml otopina za injekciju Puregon 200 IU/0,5 ml otopina za injekciju Puregon 225 IU/0,5 ml otopina za injekciju folitropin beta
English: To prevent painful injections and minimise leakage from the injection site Puregon should be slowly administered intramuscularly or subcutaneously.
Croatian: Puregon se mora primijeniti polaganom intramuskularnom ili supkutanom injekcijom kako bi se spriječila bol i smanjilo kapanje iz mjesta uboda.
English: Puregon 50 IU/0.5 mL solution for injection Puregon 75 IU/0.5 mL solution for injection Puregon 100 IU/0.5 mL solution for injection Puregon 150 IU/0.5 mL solution for injection Puregon 200 IU/0.5 mL solution for injection Puregon 225 IU/0.5 mL solution for injection
Croatian: Puregon 50 IU/0,5 ml otopina za injekciju Puregon 75 IU/0,5 ml otopina za injekciju Puregon 100 IU/0,5 ml otopina za injekciju Puregon 150 IU/0,5 ml otopina za injekciju Puregon 200 IU/0,5 ml otopina za injekciju Puregon 225 IU/0,5 ml otopina za injekciju
English: The concurrent determination of serum oestradiol levels may also be useful.The patients should be advised of the potential risks of multiple births before starting treatment.
Croatian: Prije početka liječenja bolesnice se mora upozoriti na moguće rizike višeplodne trudnoće.
English: CARTRIDGE TEXT Puregon 150 IU/0.18 mL
Croatian: TEKST NA ULOŠKU Puregon 150 IU/0,18 ml
English: Puregon 225 IU/0.5 mL solution for injection
Croatian: Puregon 225 IU/0,5 ml otopina za injekciju
English: OUTER CARTON TEXT Puregon 900 IU/1.08 mL 1 cartridge
Croatian: TEKST NA KUTIJI - Puregon 900 IU/1,08 ml 1 uložak
English: Puregon solution for injection in cartridges has been developed for use in the Puregon Pen.
Croatian: Puregon otopina za injekciju u ulošcima namijenjena je za primjenu u injekcijskoj brizgalici Puregon Pen.
English: In women who do not ovulate and do not respond to treatment with clomifene citrate, Puregon can be used to cause ovulation.
Croatian: Puregon se može primjenjivati za izazivanje ovulacije u žena koje nemaju ovulaciju i nisu odgovorile na liječenje klomifen citratom.
English: Multiple gestation, especially high order, carries an increased risk of adverse maternal (pregnancy and delivery complications) and perinatal (low birth weight) outcomes.For anovulatory women undergoing ovulation induction, monitoring follicular development with transvaginal ultrasonography may aid in determining whether or not to continue the cycle in order to reduce the risk of multiple pregnancies.
Croatian: Kod žena s anovulacijskim ciklusima koje prolaze indukciju ovulacije, nadziranje razvoja folikula pomoću transvaginalnog ultrazvuka može pomoći da se odredi nastaviti ili ne s ciklusom kako bi se smanjio rizik od višeplodne trudnoće.
English: If Puregon is used in a combination with clomifene citrate, the effect of Puregon may be increased.
Croatian: Učinak lijeka Puregon može biti povećan ako se koristi u kombinaciji s klomifen citratom.
English: Restricted to women with ovulation induced (Puregon, n = 76; u-FSH, n = 42).
Croatian: * Razlike između 2 skupine bile su statistički značajne (p0,05). ograničeno na žene s potaknutom ovulacijom (Puregon, n=76; u-FSH, n=42).
English: OUTER CARTON TEXT Puregon 300 IU/0.36 mL 1 cartridge
Croatian: TEKST NA KUTIJI - Puregon 300 IU/0,36 ml 1 uložak
English: Puregon 900 IU/1.08 mL solution for injection EU/1/96/008/041
Croatian: Puregon 900 IU/1,08 ml otopina za injekciju EU/1/96/008/041
English: Puregon 75 IU/0.5 mL solution for injection
Croatian: Puregon 75 IU/0,5 ml otopina za injekciju
English: Puregon 300 IU/0.36 mL solution for injection EU/1/96/008/038
Croatian: Puregon 300 IU/0,36 ml otopina za injekciju EU/1/96/008/038
English: OUTER CARTON TEXT Puregon 225 IU/0.5 mL 1, 5 or 10 vials
Croatian: TEKST NA KUTIJI - Puregon 225 IU/0,5 ml 1, 5 ili 10 bočica
English: OUTER CARTON TEXT Puregon 600 IU/0.72 mL 1 cartridge
Croatian: TEKST NA KUTIJI - Puregon 600 IU/0,72 ml 1 uložak
English: Puregon 150 IU/0.18 mL solution for injection EU/1/96/008/040
Croatian: Puregon 150 IU/0,18 ml otopina za injekciju EU/1/96/008/040
English: VIAL TEXT Puregon 150 IU/0.5 mL
Croatian: TEKST NA BOČICI Puregon 150 IU/0,5 ml
English: Puregon 300 IU/0.36 mL injection follitropin beta
Croatian: Puregon 300 IU/0,36 ml injekcija folitropin beta s.c.
English: OUTER CARTON TEXT Puregon 150 IU/0.18 mL 1 cartridge
Croatian: TEKST NA KUTIJI - Puregon 150 IU/0,18 ml 1 uložak
English: Puregon 225 IU/0.5 mL injection follitropin beta
Croatian: Puregon 225 IU/0,5 ml otopina za injekciju folitropin beta
English: Puregon 900 IU/1.08 mL injection follitropin beta
Croatian: Puregon 900 IU/1,08 ml otopina za injekciju folitropin beta
English: Puregon 150 IU/0.18 mL solution for injection
Croatian: Puregon 150 IU/0,18 ml otopina za injekciju
English: Puregon 600 IU/0.72 mL injection follitropin beta
Croatian: Puregon 600 IU/0,72 ml injekcija folitropin beta s.c.
English: Puregon 600 IU/0.72 mL solution for injection EU/1/96/008/039
Croatian: Puregon 600 IU/0,72 ml otopina za injekciju EU/1/96/008/039
English: 1 vial contains 0.5 mL follitropin beta corresponding to: 225 IU (450 IU/mL) recombinant follicle-stimulating hormone (FSH) activity.
Croatian: 1 bočica sadrži 0,5 ml folitropina beta, što odgovara: 225 IU (450 IU/ml) aktivnosti rekombinantnog folikulostimulirajućeg hormona (FSH).
English: Puregon 225 IU/0.5 mL solution for injection: Each vial contains the active substance follitropin beta, a hormone known as follicle-stimulating hormone (FSH), in a strength of 225 IU in 0.5 mL aqueous solution per vial.
Croatian: Puregon 225 IU/0,5 ml otopina za injekciju: Jedna bočica sadrži djelatnu tvar folitropin beta, hormon poznat kao folikulostimulirajući hormon (FSH) u koncentraciji od 225 IU u 0,5 ml vodene otopine po bočici.
English: VIAL TEXT Puregon 200 IU/0.5 mL
Croatian: TEKST NA BOČICI Puregon 200 IU/0,5 ml
English: VIAL TEXT Puregon 100 IU/0.5 mL
Croatian: TEKST NA BOČICI Puregon 100 IU/0,5 ml
English: Puregon 75 IU/0.5 mL injection follitropin beta
Croatian: Puregon 75 IU/0,5 ml otopina za injekciju folitropin beta
English: Puregon 225 IU/0.5 mL solution for injection EU/1/96/008/032
Croatian: Puregon 225 IU/0,5 ml otopina za injekciju EU/1/96/008/032
English: VIAL TEXT Puregon 50 IU/0.5 mL
Croatian: TEKST NA BOČICI Puregon 50 IU/0,5 ml
English: Ovarian torsion has been reported after treatment with gonadotropins, including Puregon.
Croatian: Nakon liječenja gonadotropinima, uključujući Puregon, prijavljena je torzija jajnika.
English: Ovarian torsion has occurred after treatment with gonadotropins including Puregon.
Croatian: Nakon liječenja gonadotropinima, uključujući i Puregon, nastala je torzija jajnika.
English: Puregon 75 IU/0.5 mL solution for injection: Each vial contains the active substance follitropin beta, a hormone known as follicle-stimulating hormone (FSH), in a strength of 75 IU in 0.5 mL aqueous solution per vial.
Croatian: Puregon 75 IU/0,5 ml otopina za injekciju: Jedna bočica sadrži djelatnu tvar folitropin beta, hormon poznat kao folikulostimulirajući hormon (FSH) u koncentraciji od 75 IU u 0,5 ml vodene otopine po bočici.
English: Puregon 75 IU/0.5 mL solution for injection EU/1/96/008/020
Croatian: Puregon 75 IU/0,5 ml otopina za injekciju EU/1/96/008/020
English: Puregon 150 IU/0.18 mL injection follitropin beta
Croatian: Puregon 150 IU/0,18 ml injekcija folitropin beta s.c.
English: Puregon 200 IU/0.5 mL solution for injection EU/1/96/008/029
Croatian: Puregon 200 IU/0,5 ml otopina za injekciju EU/1/96/008/029
English: OUTER CARTON TEXT Puregon 75 IU/0.5 mL 1, 5 or 10 vials
Croatian: TEKST NA KUTIJI - Puregon 75 IU/0,5 ml 1, 5 ili 10 bočica
English: Puregon 200 IU/0.5 mL solution for injection
Croatian: Puregon 200 IU/0,5 ml otopina za injekciju
English: Puregon 100 IU/0.5 mL solution for injection EU/1/96/008/023
Croatian: Puregon 100 IU/0,5 ml otopina za injekciju EU/1/96/008/023
English: One vial contains 22.5 microgram of protein (specific in vivo bioactivity equal to approximately 10,000 IU FSH / mg protein).
Croatian: Jedna bočica sadrži 22,5 mikrograma proteina (čija specifična in vivo biološka aktivnost odgovara približno 10 000 IU FSH/mg proteina).
English: One vial contains 225 IU recombinant follicle-stimulating hormone (FSH) in 0.5 mL aqueous solution.
Croatian: Jedna bočica sadrži 225 IU rekombinantnog folikulostimulirajućeg hormona (FSH) u 0,5 ml vodene otopine, što odgovara koncentraciji od 450 IU/ml.